Tag: Cancer: Breast
Attending Surgeon Influences Genetic Testing in Breast Cancer
About one-third of surgeon variation explained by patient volume, surgeon attitudes to genetic testing
Risk-Stratified Breast Cancer Screening Ups Cost-Effectiveness
Risk-stratified screening can reduce overdiagnosis and maintain benefits of screening
Higher Cancer Rates Confirmed in Women With Dense Breasts
Higher rate of recall, lower sensitivity, larger tumor diameter, and more lymph node-positive disease
Increased Adiposity Tied to Lower Premenopausal Breast CA Risk
Largest reductions in risk were seen for women aged 18 to 24 years, with hazard ratio of 0.77
Greater Satisfaction With Autologous Breast Reconstruction
And, likelihood of complications up for autologous reconstruction versus expander-implant technique
ASCO: Ovarian Suppression + Tamoxifen Ups Breast CA Survival
Increased disease-free, overall survival for premenopausal women with breast cancer
Many Breast Cancer Survivors Do Not Undergo Annual Surveillance
In year 1, 13 percent did not undergo MRI or mammography; up to 19 percent by year 5
Personalized Therapy Promising in Metastatic Breast Cancer
Adaptive transfer of mutant-protein-specific tumor-infiltrating lymphocytes leads to disease regression
ASCO: Endocrine Tx Noninferior for HR+, HER2− Breast Cancer
Similar efficacy for endocrine, chemoendocrine tx for women with midrange 21-gene recurrence score
Poor Prognosis for Interval Breast Cancer After Negative Mammo
Odds of poor prognosis after mammography with negative results higher for younger women
